Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

DNA-enabled rational design of fluorescence-Raman bimodal nanoprobes for cancer imaging and therapy

FRNPs selectively accumulate in tumor tissue mouse cancer models and enable real-time fluorescence imaging for tumor detection, resection, and subsequent Raman-based verification of clean margins.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report designing fluorescence-Raman bimodal nanoparticles using DNA-based engineering to combine fluorescence imaging speed with Raman spectral specificity. In mouse cancer models, the particles reportedly accumulated in tumors, supported real-time fluorescence tumor detection and resection, and enabled image-guided photothermal ablation. The abstract reports these results without describing sample sizes or control groups.

Who or what was studied
Mouse cancer models
Limits stated in the abstract
The abstract describes preclinical mouse work only and does not report sample sizes, controls, or clinical translation.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Recently, surface-enhanced Raman scattering nanoprobes have shown tremendous potential in oncological imaging owing to the high sensitivity and specificity of their fingerprint-like spectra. As current Raman scanners rely on a slow, point-by-point spectrum acquisition, there is an unmet need for faster imaging to cover a clinically relevant area in real-time. Herein, we report the rational design and optimization of fluorescence-Raman bimodal nanoparticles (FRNPs) that synergistically combine the specificity of Raman spectroscopy with the versatility and speed of fluorescence imaging. DNA-enabled molecular engineering allows the rational design of FRNPs with a detection limit as low as 5 × 10-15 M. FRNPs selectively accumulate in tumor tissue mouse cancer models and enable real-time fluorescence imaging for tumor detection, resection, and subsequent Raman-based verification of clean margins. Furthermore, FRNPs enable highly efficient image-guided photothermal ablation of tumors, widening the scope of the NPs into the therapeutic realm.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies